Hospital Pharmacy Europe - Infectious disease,

Click here

Saturday 25 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Infectious disease

Magazine	Sponsored content
News	Video

Page:

1

Fri 24 May

Fight against infections
Arcolectric – an Elektron Technology connectivity brand – has partnered with BioCote Ltd to offer a range of switches...

Mon 20 May

Sepsis code
Hospital Marina Salud de Dénia has presented its Sepsis Code at the National Health IT Conference and Exhibition, which...

Wed 1 May

Combination drugs are the future for hepatitis B and C
The limited efficacy and negative side-effects associated with current therapeutics for Hepatitis B and C are highlighting the...

Mon 29 Apr

Novartis signs on to support malaria campaign
Novartis and Malaria No More, a leading global charity determined to end malaria deaths, announced today that they are joining...

Mon 29 Apr

Incivo® receives positive opinion
Janssen Infectious Diseases-Diagnostics BVBA (Janssen), has announced that the Committee for Medicinal Products for Human Use...

Wed 24 Apr

Janssen submits marketing authorisation application for Simeprevir
Janssen-Cilag International NV (Janssen) has announced it has submitted a marketing authorisation application to the European...

Mon 22 Apr

Diagnosis and management of CDI
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial)...

Fri 19 Apr

Crucial changes needed to improve the diagnosis and management of CDI
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial)...

Wed 17 Apr

First patient enrolled in global Phase III program evaluating Bayer's Amikacin Inhale
Bayer HealthCare has announced the successful enrolment of the first patient in a global Phase III program, INHALE, which will...

Thu 4 Apr

Roche releases all trial data on Tamiflu drug
The BMJ can reveal that following over three years of talks with pharmaceutical giant Roche, the Cochrane Collaboration is at...

Tue 2 Apr

Diagnosis and management of ToRC
The key features and diagnosis of maternal and congenital toxoplasmosis, rubella and cytomegalovirus (ToRC) infections, and their...

Fri 22 Mar

CHMP positive opinion for Stribild
Gilead Sciences, Inc. (Nasdaq: GILD) has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific...

Wed 20 Mar

Data from Marinomed's antiviral drug
The pooled analysis of data from two clinical studies has once again proven the effectiveness of an innovative antiviral nasal...

Wed 20 Mar

Anti-microbial plastic reduces threat of antibiotic-resistant bugs
The UK’s Chief Medical Officer has warned that there is a 'catastrophic threat' of resistance to antibiotics. In a special...

Mon 4 Mar

Rheumatic heart disease
Novartis has announced that it has launched an effort to eliminate rheumatic heart disease in Zambia in collaboration with the...

Thu 21 Feb

UNITAID - Financed project to increase access to new HIV monitoring technology
UNITAID and France Expertise Internationale (FEI) signed a US$ 2.4 million agreement to implement the 'OPP-ERA' project which...

Fri 8 Feb

Glenmark launches first UK generic
Glenmark Generics (Europe) Limited (GGEL) has announced the first generic launch of Atovaquone Proguanil in the UK following the...

Fri 25 Jan

Paediatric profile for seasonal influenza vaccine candidate Immunose™ FLU
Eurocine Vaccines’ nasal seasonal influenza vaccine candidate Immunose™ FLU will be profiled towards the pediatric...

Wed 16 Jan

European commission approves PREZISTA®
Janssen R&D Ireland has announced that the European Commission (EC) has approved a new PREZISTA® (darunavir) 800mg...

Tue 15 Jan

Economist Intelligence Unit report calls for global policy innovation
A new Economist Intelligence Unit (EIU) report titled 'The Silent Pandemic: Tackling Hepatitis C with Policy Innovation', made...

Page:

1

Web design, hosting and programming by ModeZero